An old flame: The e‐cigarette industry advertises, addicts, and challenges scientific evidence using the cigarette industry playbook

Chiel, Laura; Kass, Alexandra; Casey, Alicia

doi:10.1002/ppul.24612

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Numerous professional societies, including the American Academy of Pediatrics 83 and the Forum of International Respiratory Societies 84 have outlined policy statements calling for a prohibition of ENDS sales to adolescents and young adults, marketing regulations and a ban on use of flavorings. These efforts are often combatted by powerful tobacco and ENDS industry lobbying efforts that often involve significant political contributions and opposition to government regulation 85 . Given the unknown long‐term health effects of ENDS use and known association with transition to traditional cigarettes, continued efforts at reducing ENDS initiation in adolescents and young adults is paramount.…”

Section: Opportunities For Health Policy Implementationmentioning

confidence: 99%

E‐cigarette and vaping product use‐associated lung injury in the pediatric population: A critical review of the current literature

Kaslow

Rosas‐Salazar

Moore

2021

Pediatric Pulmonology

View full text Add to dashboard Cite

Use of electronic nicotine delivery systems (ENDS), also known as e‐cigarettes, in the adolescent population has significantly increased over the past several years. This rise led to an outbreak of e‐cigarette or vaping product use‐associated lung injury (EVALI) in the summer of 2019. Since that time, numerous case reports and case series on vaping and EVALI have been published but the majority of literature highlights the adult population with few articles focusing on pediatric patients. Given the addictive nature of these products and the lack of full understanding of the human health effects, there is concern that use of ENDS may have lasting impacts on users, especially adolescents and young adults. The goal of this review is to critically assess published data on ENDS use in children, report our institutional experience, discuss the reasons why the use of ENDS have increased among young individuals, outline the current understanding of EVALI as it pertains to the pediatric population, and discuss future opportunities for health policy implementation.

show abstract

Section: Opportunities For Health Policy Implementationmentioning

confidence: 99%